Companies / Transposon Therapeutics
Transposon Therapeutics
United States
Transposon Therapeutics develops therapies for neurodegenerative and aging-related diseases
Transposon Therapeutics, based in United States, has 2 investors on file, among them Canaan and Lumira Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Canaan
201 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (21%), AI & Machine Learning (17%), Fintech (12%).
More from Lumira Ventures
46 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (96%), Media & Entertainment (2%), Education (2%).
See Lumira Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Transposon Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Canaan adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/transposonrx.com/investors
# also
GET /v1/companies/transposonrx.com
GET /v1/companies/transposonrx.com/news